APOTEA — Apotea Sverige AB Balance Sheet
0.000.00%
Consumer DefensivesSpeculativeMicro Cap
Annual balance sheet for Apotea Sverige AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PRESS | PRESS |
Standards: | IFRS | IFRS | — | — |
Status: | Final | Final | Final | Final |
Cash and Equivalents | ||||
Short Term Investments | ||||
Cash and Short Term Investments | 81.7 | 18.2 | 19.2 | 27.3 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 275 | 283 | 337 | 407 |
Total Inventory | ||||
Prepaid Expenses | ||||
Total Current Assets | 714 | 721 | 782 | 1,021 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 289 | 462 | 491 | 547 |
Net Goodwill | ||||
Net Intangible Assets | ||||
Long Term Investments | ||||
Other Long Term Assets | ||||
Total Assets | 1,029 | 1,253 | 1,336 | 1,628 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 562 | 716 | 757 | 881 |
Capital Lease Obligations | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Deferred Income Tax | ||||
Minority Interest | ||||
Total Other Liabilities | ||||
Total Liabilities | 688 | 925 | 933 | 1,013 |
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Other Equity | ||||
Total Equity | 341 | 328 | 404 | 615 |
Total Liabilities & Shareholders' Equity | 1,029 | 1,253 | 1,336 | 1,628 |
Total Common Shares Outstanding |